	CCDC78 is required for prostate cancer cell growth and serves as a prognostic biomarker for high-risk disease. Discov Oncol Zhu L, Liang W. PMID: 42162449 [PubMed - as supplied by publisher]
	Predictive risk model for bone metastasis in intermediate-risk prostate cancer: a single-center retrospective analysis. Sci Rep Zhu J, Shen C, Wang Z, Chen F, Wang T. PMID: 42162156 [PubMed - as supplied by publisher]
	Individual Patient Data Validation of the EAU Definitions of BCG Failure in Patients with Non-muscle-invasive Urothelial Carcinoma of the Bladder: An International Multicenter Retrospective Study. Eur Urol Oncol Gontero P, Soria F, Babjuk M, Burger M, Palou Redorta J, D'Andrea D, Pradere B, Moschini M, Birtle A, Compérat EM, Dominguez-Escrig JL, Liedberg F, Mariappan P, van Rhijn BWG, Seisen T, Shariat SF, Teoh J, Xylinas E, Capoun O, Rai BP, Soukup V, Faba OR, Cohen D, Foster L, Beaud N, Girtner F, Breyer J, Hornak J, Einerhand SMH, Anract J, Bobjer J, Linares E, Rodriguez-Serranos A, Cathomas R, Saba K, Hernandez V, Lorente C, Rouanne M, Lebret T, Masson-Lecomte A, Rouprêt M, Sylvester RJ. PMID: 42161743 [PubMed - as supplied by publisher]
	Re: Gallagher et al. RESECT, A Randomised Controlled Trial of Audit and Feedback in Non-muscle-invasive Bladder Cancer Surgery. Eur Urol 2026. In press. http://dx.doi.org/10.1016/j.eururo.2025.09.4174. Eur Urol Di Bello F, Gallioli A, Diana P, Avesani G, Palou J, Breda A. PMID: 42161693 [PubMed - as supplied by publisher]
	From Evidence to Implementation: How Should We Screen for Prostate Cancer in the Modern Era?: Editorial to: Nguyen DD, Tadayon B, Lin L, et al. Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol. 2026. In press. https://doi.org/10.1016/j.eururo.2026.04.005. Eur Urol Al-Monajjed R, Albers P, van Poppel H, Bratt O, Roobol MJ. PMID: 42161692 [PubMed - as supplied by publisher]
	Efficacy and Safety of Enzalutamide and Abiraterone in CRPC Patients With a History of Other Cancers: A Sub-Analysis of the ENABLE Study for PCa. Int J Urol Hoshi S, Izumi K, Meguro S, Shima T, Kato Y, Mita K, Okamura T, Inoue S, Tatarano S, Tanaka N, Yoshio Y, Kamiyama M, Chikazawa I, Kawai N, Hashimoto K, Fukagai T, Shigehara K, Takahara S, Mizokami A. PMID: 42161369 [PubMed - indexed for MEDLINE]
	Real-World Representation in Prostate Cancer Clinical Trials: Needs and Opportunities. J Natl Compr Canc Netw McManus HD, George DJ, Shevach JW. PMID: 42161307 [PubMed - as supplied by publisher]
	A Real-World Prospective Study of Comprehensive Genomic Testing in Patients With Metastatic Castration-Resistant Prostate Cancer. Clin Genitourin Cancer Shevrin D, Yang M, Sabatini LM, Akroush M, Pfanzelter N, Alnajar H, Wittich H, Helseth DL. PMID: 42161163 [PubMed - as supplied by publisher]
	Artificial Intelligence Remote Patient Monitoring for Predicting Overall Survival for Patients Undergoing Radical Cystectomy for Bladder Cancer: Exploratory Analysis of the Prospective Trial. JMIR AI Liu Y, Khetrapal P, Strafford R, Hadjivasilou A, Vasdev N, Charlesworth P, Khan MS, Abdulaal A, Dong Z, Catto JWF, Zhou Y, Kelly JD, Drobnjak I. PMID: 42160502 [PubMed]
	Prognostic Significance of Pretreatment Blood-Based Biomarkers in Penile Cancer: A Multicenter Retrospective Study in Japan. Int J Urol Tatarano S, Miyake M, Osaki Y, Daizumoto K, Wada K, Kobayashi K, Kato M, Fukuhara H, Tsujino T, Kobatake K, Taoka R, Furukawa J, Ogawa K, Shiraishi K, Matsue T, Inoue K, Maenosono R, Sekino Y, Fujimoto K, Enokida H, West Japan Uro. PMID: 42160476 [PubMed - indexed for MEDLINE]
	Real-World Occurrence of Adverse Events Associated With Adjuvant Pembrolizumab Therapy for Renal Cell Carcinoma: A Multicenter Retrospective Study. Int J Urol Iinuma K, Nishikawa K, Sano Y, Ozawa K, Yamada T, Taniguchi T, Nakane K, Inoue T, Akamatsu S, Koie T. PMID: 42160469 [PubMed - indexed for MEDLINE]
	Failure of a LHRH agonist in metastatic prostate cancer: a case report and review of literature. Cancer Chemother Pharmacol Paganoni E, Sabbadini P, D'Avolio A, Cusato J, Motta G, Galeasso L, Filippi R, Di Maio M, Depetris I. PMID: 42159776 [PubMed - indexed for MEDLINE]
	Clinical indicators combined with spectral CT in differentiating non-muscle-invasive bladder urothelial carcinoma from cystitis glandularis. Abdom Radiol (NY) Han Y, She Y, Wei J, Zhang X, Zhou J. PMID: 42159673 [PubMed - as supplied by publisher]
	Refining Prognosis in Advanced Renal Cell Carcinoma: International Real-World Validation of the Meet-URO Score in First-Line Immunotherapy Combinations. Oncologist Rebuzzi SE, Ghose A, Rudman S, Venugopal B, Young K, Frazer RD, Ayodele O, Stares M, O'Carrigan B, Ali W, McGrane J, Jain A, Fiala O, Chauhan V, Michael A, Zarkar A, Kapur G, Charnley N, Afshar M, Vengalil S, Forde C, Brown J, Urun Y, Bianchini D, Bahl A, Srihari N, Di Costanzo F, Smalley B, Parkes J, Crabb S, Vasudev N, Poprach A, Brown N, James L, Haywood S, Tapia J, Vijay A, Parry J, Cheung M, Mahajan I, Moon NO, Abrol R, Tkadlecová M, Yee Soe YS, Zargham A, Smith M, Ashley S, Hardy O, Patel G, Tun KK, Johnston E, Sarwer A, Bölek H, Shrestha R, Challapalli A, Meegan J, Anpalakhan S, Buono F, Kolarikova E, Leung DK, Murianni V, Catalano F, Bimbatti D, Buti S, Signori A, Fornarini G, Rescigno P, Chun Teoh JY, Banna GL. PMID: 42159577 [PubMed - as supplied by publisher]
	The impact of low-volume hydration on kidney function in low-dose cisplatin therapy for biliary tract cancer: a multicentre retrospective cohort study. J Chemother Watanabe H, Makihara K, Nakao M, Haruta M, Takahashi M, Yamase H, Hosoda M, Kongo K, Takatori H, Kondo A, Yamamoto H, Kimura N, Takahashi K. PMID: 42159361 [PubMed - as supplied by publisher]
	Development and Validation of a Cuproptosis-Related Gene Signature for Prognostic Stratification in Papillary Renal Cell Carcinoma. Clin Lab Li H, Cao L, Li R, Xu L, Zhang S, Gao J, Chen Y, Lian X. PMID: 42159135 [PubMed - indexed for MEDLINE]
	Cluster Randomized Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191. Hypertension Ky B, Liu T, Margulies KB, Mitchell JD, Haas NB, Gareen IF, Thangarajah M, Sicks JD, Domenico C, Narayan VK, Smith AM, Wilcox NS, Mittal K, Rhee JW, Armenian SH, Saphner T, Paul AK, Gartrell BA, Zaha VG, Anari F, Wong RL, Townsend RR, Wagner LI. PMID: 42158981 [PubMed - as supplied by publisher]
	Mapping research trends in macrophage polarization and immunotherapeutic potential in prostate cancer: a bibliometric and visual analysis. Front Oncol Wu P, Chen L, Yang J, He C, Tang A, Yang Y. PMID: 42158438 [PubMed]
	Photodynamic Therapy Combined with Gemcitabine for Prostate Cancer Using Nanoprobe for in-vivo CEST Imaging. Iran J Pharm Res Fu Q, Liu Q, Zeng X, Wang L, Yan J, He D, Xie J. PMID: 42157805 [PubMed]
	Clinical Outcomes of the Alternative GAMMA Regimen in Relapsed Germ Cell Tumours. Cancer Med Aziz NA, Ng K, Rajan P, Shamash J. PMID: 42157361 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 178372

Page 1 of 8919



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy